» Articles » PMID: 29796672

Bidirectional Regulation of Adenosine-to-inosine (A-to-I) RNA Editing by DEAH Box Helicase 9 (DHX9) in Cancer

Overview
Specialty Biochemistry
Date 2018 May 26
PMID 29796672
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine-to-inosine (A-to-I) RNA editing entails the enzymatic deamination of adenosines to inosines by adenosine deaminases acting on RNA (ADARs). Dysregulated A-to-I editing has been implicated in various diseases, including cancers. However, the precise factors governing the A-to-I editing and their physiopathological implications remain as a long-standing question. Herein, we unravel that DEAH box helicase 9 (DHX9), at least partially dependent of its helicase activity, functions as a bidirectional regulator of A-to-I editing in cancer cells. Intriguingly, the ADAR substrate specificity determines the opposing effects of DHX9 on editing as DHX9 silencing preferentially represses editing of ADAR1-specific substrates, whereas augments ADAR2-specific substrate editing. Analysis of 11 cancer types from The Cancer Genome Atlas (TCGA) reveals a striking overexpression of DHX9 in tumors. Further, tumorigenicity studies demonstrate a helicase-dependent oncogenic role of DHX9 in cancer development. In sum, DHX9 constitutes a bidirectional regulatory mode in A-to-I editing, which is in part responsible for the dysregulated editome profile in cancer.

Citing Articles

Deletion of Ovary-Specific Transcript Causes Dysfunction of Meiosis and Derepress of DNA Transposons in Zebrafish Ovaries.

Chen Y, Lin X, Dai J, Bai Y, Liu F, Luo D Biology (Basel). 2025; 13(12.

PMID: 39765722 PMC: 11673608. DOI: 10.3390/biology13121055.


Identification of the whole genome of alternative splicing and RNA-binding proteins involved in nintedanib-induced apoptosis in gastric cancer cells.

Dong X, Liu Z, Yu M, Yang X, Cai H PeerJ. 2024; 12:e18697.

PMID: 39726754 PMC: 11670762. DOI: 10.7717/peerj.18697.


Distinct interactomes of ADAR1 nuclear and cytoplasmic protein isoforms and their responses to interferon induction.

Vukic D, Cherian A, Keskitalo S, Bong Y, Maronek M, Yadav L Nucleic Acids Res. 2024; 52(22):14184-14204.

PMID: 39673305 PMC: 11662693. DOI: 10.1093/nar/gkae1106.


Adenosine deaminases that act on RNA, then and now.

Bass B RNA. 2024; 30(5):521-529.

PMID: 38531651 PMC: 11019741. DOI: 10.1261/rna.079990.124.


Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells.

Cottrell K, Ryu S, Pierce J, Torres L, Bohlin H, Schab A Cancer Res Commun. 2024; 4(4):986-1003.

PMID: 38530197 PMC: 10993856. DOI: 10.1158/2767-9764.CRC-23-0488.


References
1.
Jankowsky E . RNA helicases at work: binding and rearranging. Trends Biochem Sci. 2010; 36(1):19-29. PMC: 3017212. DOI: 10.1016/j.tibs.2010.07.008. View

2.
Maas S, Kawahara Y, Tamburro K, Nishikura K . A-to-I RNA editing and human disease. RNA Biol. 2006; 3(1):1-9. PMC: 2947206. DOI: 10.4161/rna.3.1.2495. View

3.
Chan T, Qamra A, Tan K, Guo J, Yang H, Qi L . ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer. Gastroenterology. 2016; 151(4):637-650.e10. PMC: 8286172. DOI: 10.1053/j.gastro.2016.06.043. View

4.
Liu Y, Emeson R, Samuel C . Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J Biol Chem. 1999; 274(26):18351-8. DOI: 10.1074/jbc.274.26.18351. View

5.
Cenci C, Barzotti R, Galeano F, Corbelli S, Rota R, Massimi L . Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem. 2008; 283(11):7251-60. DOI: 10.1074/jbc.M708316200. View